143 related articles for article (PubMed ID: 10706882)
1. Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas(+) organs.
Zeytun A; Nagarkatti M; Nagarkatti PS
Blood; 2000 Mar; 95(6):2111-7. PubMed ID: 10706882
[TBL] [Abstract][Full Text] [Related]
2. Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.
Lombard C; McKallip RJ; Hylemon PB; Nagarkatti PS; Nagarkatti M
Clin Immunol; 2003 Nov; 109(2):144-53. PubMed ID: 14597213
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy.
Nagarkatti N
Cancer Immunol Immunother; 2000 Apr; 49(1):46-55. PubMed ID: 10782865
[TBL] [Abstract][Full Text] [Related]
4. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
Kamath AB; Camacho I; Nagarkatti PS; Nagarkatti M
Toxicol Appl Pharmacol; 1999 Oct; 160(2):141-55. PubMed ID: 10527913
[TBL] [Abstract][Full Text] [Related]
5. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers.
Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S
Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428
[TBL] [Abstract][Full Text] [Related]
6. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
[TBL] [Abstract][Full Text] [Related]
8. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
[TBL] [Abstract][Full Text] [Related]
9. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.
Do Y; Ryu S; Nagarkatti M; Nagarkatti PS
Toxicol Sci; 2002 Nov; 70(1):63-72. PubMed ID: 12388836
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
[TBL] [Abstract][Full Text] [Related]
11. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
[TBL] [Abstract][Full Text] [Related]
12. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.
Shen DF; Matteson DM; Tuaillon N; Suedekum BK; Buggage RR; Chan CC
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2031-6. PubMed ID: 11481268
[TBL] [Abstract][Full Text] [Related]
13. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
14. Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury.
Du C; Guan Q; Yin Z; Masterson M; Zhong R; Jevnikar AM
Transplant Proc; 2003 Nov; 35(7):2481-2. PubMed ID: 14611992
[TBL] [Abstract][Full Text] [Related]
15. Thymocyte apoptosis by T-2 toxin in vivo in mice is independent of Fas/Fas ligand system.
Murshedul AM; Nagase M; Yoshizawa T; Sakato N
Biosci Biotechnol Biochem; 2000 Jan; 64(1):210-3. PubMed ID: 10766511
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of solid tumor growth by Fas ligand-expressing myoblasts.
Springer ML; Kraft PE; Blau HM
Somat Cell Mol Genet; 1998 Sep; 24(5):281-9. PubMed ID: 10696236
[TBL] [Abstract][Full Text] [Related]
17. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
[TBL] [Abstract][Full Text] [Related]
18. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
19. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
Fecho K; Bentley SA; Cohen PL
Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554
[TBL] [Abstract][Full Text] [Related]
20. FAS/FAS ligand interaction at the placental interface is not required for the success of allogeneic pregnancy in anti-paternal MHC preimmunized mice.
Chaouat G; Clark DA
Am J Reprod Immunol; 2001 Feb; 45(2):108-15. PubMed ID: 11216873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
